vs

Side-by-side financial comparison of EMERSON RADIO CORP (MSN) and NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC). Click either name above to swap in a different company.

NEUROONE MEDICAL TECHNOLOGIES Corp is the larger business by last-quarter revenue ($2.9M vs $1.9M, roughly 1.5× EMERSON RADIO CORP). EMERSON RADIO CORP runs the higher net margin — -36.7% vs -49.7%, a 13.0% gap on every dollar of revenue. On growth, NEUROONE MEDICAL TECHNOLOGIES Corp posted the faster year-over-year revenue change (-11.7% vs -52.8%). Over the past eight quarters, NEUROONE MEDICAL TECHNOLOGIES Corp's revenue compounded faster (44.9% CAGR vs -7.3%).

Emerson Radio Corporation is one of the United States' largest volume consumer electronics distributors and has a recognized trademark in continuous use since 1912. The company designs, markets, and licenses many product lines worldwide, including products sold, and sometimes licensed, under the brand name G Clef, an homage to Emerson's logo.

NeuroOne Medical Technologies Corp is a medical technology company specializing in the development and commercialization of diagnostic and therapeutic neurological devices for conditions including epilepsy, movement disorders, and chronic pain. Its core products include minimally invasive cortical monitoring electrodes and neurostimulation systems, primarily serving neurology and neurosurgical care providers across North America.

MSN vs NMTC — Head-to-Head

Bigger by revenue
NMTC
NMTC
1.5× larger
NMTC
$2.9M
$1.9M
MSN
Growing faster (revenue YoY)
NMTC
NMTC
+41.1% gap
NMTC
-11.7%
-52.8%
MSN
Higher net margin
MSN
MSN
13.0% more per $
MSN
-36.7%
-49.7%
NMTC
Faster 2-yr revenue CAGR
NMTC
NMTC
Annualised
NMTC
44.9%
-7.3%
MSN

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
MSN
MSN
NMTC
NMTC
Revenue
$1.9M
$2.9M
Net Profit
$-694.0K
$-1.4M
Gross Margin
10.9%
54.2%
Operating Margin
-43.7%
-59.0%
Net Margin
-36.7%
-49.7%
Revenue YoY
-52.8%
-11.7%
Net Profit YoY
-31.7%
-180.5%
EPS (diluted)
$-0.03
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSN
MSN
NMTC
NMTC
Q4 25
$1.9M
$2.9M
Q3 25
$1.2M
$2.7M
Q2 25
$1.7M
$1.7M
Q1 25
$1.8M
$1.4M
Q4 24
$4.0M
$3.3M
Q3 24
$2.7M
$272.3K
Q2 24
$2.2M
$825.8K
Q1 24
$2.2M
$1.4M
Net Profit
MSN
MSN
NMTC
NMTC
Q4 25
$-694.0K
$-1.4M
Q3 25
$-1.0M
$-1.6M
Q2 25
$-1.1M
$-1.5M
Q1 25
$-2.4M
$-2.3M
Q4 24
$-527.0K
$1.8M
Q3 24
$-881.0K
Q2 24
$-962.0K
$-2.8M
Q1 24
$-883.0K
$-2.9M
Gross Margin
MSN
MSN
NMTC
NMTC
Q4 25
10.9%
54.2%
Q3 25
-0.1%
55.8%
Q2 25
0.7%
53.9%
Q1 25
-3.0%
55.6%
Q4 24
12.3%
58.9%
Q3 24
9.9%
51.8%
Q2 24
8.8%
34.1%
Q1 24
15.9%
28.3%
Operating Margin
MSN
MSN
NMTC
NMTC
Q4 25
-43.7%
-59.0%
Q3 25
-98.4%
-50.0%
Q2 25
-78.1%
-111.2%
Q1 25
-137.8%
-193.3%
Q4 24
-18.3%
52.3%
Q3 24
-40.8%
Q2 24
-55.6%
-338.3%
Q1 24
-52.2%
-209.5%
Net Margin
MSN
MSN
NMTC
NMTC
Q4 25
-36.7%
-49.7%
Q3 25
-85.8%
-59.1%
Q2 25
-68.1%
-88.5%
Q1 25
-127.9%
-163.8%
Q4 24
-13.2%
54.5%
Q3 24
-32.2%
Q2 24
-43.8%
-335.1%
Q1 24
-40.1%
-207.3%
EPS (diluted)
MSN
MSN
NMTC
NMTC
Q4 25
$-0.03
$-0.03
Q3 25
$-0.05
$-0.05
Q2 25
$-0.05
$-0.03
Q1 25
$-0.10
$-0.07
Q4 24
$-0.03
$0.06
Q3 24
$-0.04
Q2 24
$-0.05
$-0.10
Q1 24
$-0.04
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSN
MSN
NMTC
NMTC
Cash + ST InvestmentsLiquidity on hand
$13.3M
$3.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$18.6M
$6.4M
Total Assets
$20.1M
$8.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSN
MSN
NMTC
NMTC
Q4 25
$13.3M
$3.6M
Q3 25
$13.5M
$6.6M
Q2 25
$15.5M
$8.0M
Q1 25
$16.1M
$1.3M
Q4 24
$16.4M
$1.1M
Q3 24
$16.7M
$1.5M
Q2 24
$18.9M
$1.6M
Q1 24
$19.9M
$2.4M
Stockholders' Equity
MSN
MSN
NMTC
NMTC
Q4 25
$18.6M
$6.4M
Q3 25
$19.3M
$7.1M
Q2 25
$20.4M
$8.2M
Q1 25
$21.5M
$1.1M
Q4 24
$23.9M
$2.9M
Q3 24
$24.4M
$822.0K
Q2 24
$25.3M
$3.0M
Q1 24
$26.2M
$3.9M
Total Assets
MSN
MSN
NMTC
NMTC
Q4 25
$20.1M
$8.6M
Q3 25
$20.7M
$10.8M
Q2 25
$23.3M
$10.8M
Q1 25
$23.5M
$4.5M
Q4 24
$26.4M
$6.5M
Q3 24
$26.6M
$5.4M
Q2 24
$28.5M
$4.9M
Q1 24
$29.1M
$5.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSN
MSN
NMTC
NMTC
Operating Cash FlowLast quarter
$-228.0K
$-3.1M
Free Cash FlowOCF − Capex
$-3.2M
FCF MarginFCF / Revenue
-109.1%
Capex IntensityCapex / Revenue
0.0%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSN
MSN
NMTC
NMTC
Q4 25
$-228.0K
$-3.1M
Q3 25
$-2.0M
$-1.5M
Q2 25
$-514.0K
$-1.5M
Q1 25
$-391.0K
$-56.1K
Q4 24
$-293.0K
$208.0K
Q3 24
$-2.1M
$-11.0M
Q2 24
$-840.0K
$-2.4M
Q1 24
$-2.2M
$-2.2M
Free Cash Flow
MSN
MSN
NMTC
NMTC
Q4 25
$-3.2M
Q3 25
Q2 25
$-1.5M
Q1 25
Q4 24
$-301.0K
$183.6K
Q3 24
$-2.1M
$-11.1M
Q2 24
$-1.0M
$-2.4M
Q1 24
$-2.3M
$-2.2M
FCF Margin
MSN
MSN
NMTC
NMTC
Q4 25
-109.1%
Q3 25
Q2 25
-89.0%
Q1 25
Q4 24
-7.5%
5.6%
Q3 24
-77.8%
-4088.4%
Q2 24
-46.4%
-287.6%
Q1 24
-102.3%
-160.2%
Capex Intensity
MSN
MSN
NMTC
NMTC
Q4 25
0.0%
1.4%
Q3 25
0.0%
Q2 25
0.0%
2.8%
Q1 25
0.0%
Q4 24
0.2%
0.7%
Q3 24
0.3%
44.1%
Q2 24
8.2%
1.8%
Q1 24
0.5%
2.3%
Cash Conversion
MSN
MSN
NMTC
NMTC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.12×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSN
MSN

Products$1.8M95%
Other$87.0K5%

NMTC
NMTC

Segment breakdown not available.

Related Comparisons